Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management
Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management: A Randomized Controlled Trial of Efficacy and Safety
University of Brawijaya
36 participants
Jul 23, 2024
INTERVENTIONAL
Conditions
Summary
This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer
Eligibility
Inclusion Criteria7
- Unbearable cancer pain that is resistant to WHO (World Health Organization) pain ladder at least 2 weeks medication
- The patient is tired of taking medication orally or complications of current medication (respiratory depression, nausea, vomiting, opioid-induced constipation, gastrointestinal disturbances)
- Patients with pelvic floor pain diagnosed by a (Fellow of Interventional Pain Practice) FIPP-certified pain specialist
- Patients with pain in the perineum diagnosed by a FIPP-certified pain specialist
- Numerical Rating Scale \>4
- \>18 years old
- Able and willing to sign an informed consent
Exclusion Criteria8
- Refuse to be included in the research
- Blood clotting disorders (including taking anticoagulant drugs)
- Local infection in the area of action
- Loss to follow up
- Drop-out Criteria:
- Loss to follow up
- Intervention complications occur
- Failed intervention
Interventions
this procedure uses a transdiscal approach at the level of the L5-S1 vertebrae by injecting 5 ml of 1% lidocaine + 10 ml of 96% alcohol and confirmed by C-arm.
this procedure uses a trans-sacrococcygeal approach by injecting 4 ml of 1% lidocaine + 6 ml of 96% alcohol and confirmed by C-arm.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05427058